BM
Bridger Management Portfolio holdings
AUM
$170M
This Quarter Return
-4.53%
1 Year Return
+22.51%
3 Year Return
+156.88%
5 Year Return
+225.78%
10 Year Return
+854.42%
AUM
$1.43B
AUM Growth
+$1.43B
(-3%)
Cap. Flow
+$48.7M
Cap. Flow
% of AUM
3.41%
Top 10 Holdings %
Top 10 Hldgs %
47.27%
Holding
44
New
8
Increased
10
Reduced
9
Closed
9
Top Buys
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$75.6M |
| 2 |
AGN
Allergan plc
AGN
|
$67.3M |
| 3 |
UnitedHealth
UNH
|
$56.8M |
| 4 |
Incyte
INCY
|
$51.1M |
| 5 |
Merck
MRK
|
$50.9M |
Top Sells
| 1 |
Biogen
BIIB
|
$79.5M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$62.5M |
| 3 |
Humana
HUM
|
$55.1M |
| 4 |
DexCom
DXCM
|
$47.2M |
| 5 |
Pacific Biosciences
PACB
|
$44.5M |
Sector Composition
| 1 | Healthcare | 51.62% |
| 2 | Industrials | 8.88% |
| 3 | Communication Services | 8.69% |
| 4 | Consumer Discretionary | 8.55% |
| 5 | Consumer Staples | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Labcorp
LH
$22.8B
| $25.1M | 1.75% |
195,847
| – | – |
|
27
Chipotle Mexican Grill
CMG
$56B
| $24.2M | 1.68% |
64,064
+7,521
| +13% | +$2.84M |
|
28
TG Therapeutics
TGTX
$5.03B
| $22.9M | 1.59% |
4,921,059
-283,559
| -5% | -$1.32M |
|
29
Opko Health
OPK
$1.1B
| $14.2M | 0.98% |
1,523,125
| – | – |
|
|
PVG
30
DELISTED
PRETIUM RESOURCES INC.
PVG
| $13.6M | 0.95% |
1,651,328
| – | – |
|
|
MGP
31
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $12.7M | 0.88% |
500,000
| – | – |
|
32
Caesars Entertainment
CZR
$5.18B
| $11.8M | 0.82% |
+695,428
| New | +$11.8M |
|
33
Atara Biotherapeutics
ATRA
$88.7M
| $11.3M | 0.79% |
798,321
-197,755
| -20% | -$2.81M |
|
34
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $9.27M | 0.64% |
329,345
-30,541
| -8% | -$860K |
|
|
ISLE
35
DELISTED
Isle of Capri Casinos Inc
ISLE
| $5.07M | 0.35% |
+205,440
| New | +$5.07M |
|
|
36
Biogen
BIIB
$20.8B
| – | – |
-254,050
| Closed | -$79.5M |
|
37
Boyd Gaming
BYD
$6.84B
| – | – |
-1,316,060
| Closed | -$26M |
|
38
CF Industries
CF
$13.7B
| – | – |
-559,781
| Closed | -$13.6M |
|
39
Cardiff Oncology
CRDF
$130M
| – | – |
-3,290,587
| Closed | -$14.8M |
|
|
40
DexCom
DXCM
$30.9B
| – | – |
-538,859
| Closed | -$47.2M |
|
|
41
Humana
HUM
$37.5B
| – | – |
-311,235
| Closed | -$55.1M |
|
42
Lexicon Pharmaceuticals
LXRX
$392M
| – | – |
-336,966
| Closed | -$6.09M |
|
|
43
Pacific Biosciences
PACB
$378M
| – | – |
-4,964,123
| Closed | -$44.5M |
|
|
44
Teva Pharmaceuticals
TEVA
$21.5B
| – | – |
-1,358,287
| Closed | -$62.5M |
|